CareDx Inc at Raymond James Institutional Investors Conference Transcript
Thanks for joining us. I'm Andrew Cooper, the diagnostics analyst here at Raymond James. We are happy to be joined by CareDx. I think a lot of you know the story -- leading players in transplant diagnostics. I'm going to pass it over to Reg Seeto, CEO -- excuse me -- and we've got Ankur Dhingra who is going to join us for a fireside chat. But Reg is going to start us off with a little bit of a presentation, and we will go from there. So Reg, I'll turn it to you.
Great. Thanks, Andrew, and thanks, Raymond James, for the opportunity [here] to talk about CareDx. It's amazing. My last live conference was actually here two years ago. So it's actually quite interesting being back here. It feels like it was yesterday actually after the first meeting, and I can't believe there are so many people here. So it's -- just thrilled to see you all.
That said, I know it's more of a generalist conference that time, so I don't know how many people know about CareDx. So just a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |